Social media companies are so far treating the Christchurch Call and emerging global 'techlash' as a PR exercise, says tech commentator Paul Brislen. Facebook announces how it will protect users from livestreaming breaches Jacinda Ardern won't rule out blocking Facebook if used to spread extremist content Speaking to Newshub Nation, Brislen says big tech is doing the bare minimum to combat extremism online despite mounting international pressure to more tightly regulate content on their platforms. "I don't think anything they've announced so far would have changed what happened in Christchurch." "The PR element is first and foremost for these tech companies at this stage. I don't think they've really grasped just how seriously the rest of us are taking this." The non-binding Christchurch Call agreement signed by representatives of Facebook, Google and Twitter pledged to review systems which drive users toward extreme content. See full details here. But Brislen says while … [Read more...] about Scant signs of meaningful change in Silicon Valley
Silicon valley review
Elizabeth Holmes, who was once tipped to be the youngest self-made female billionaire, was said to never blink. Her invention was going to mean that “no one ever has to say goodbye too soon”: a tool that could analyse diseases from the prick of a fingertip and avoid the “torture” of needles. Where blood tests provide a snapshot of human health in time, micro-samples taken from a single drop of blood could screen a moving picture. Holmes’s mythos has captivated reporters, film makers and podcasters. Just what makes her story so compelling? In The Inventor: Out for Blood in Silicon Valley, a documentary recently screened on HBO, the latest of two made about the saga, director Alex Gibney portrays Holmes’ rise, fall, and gratifying exposure. She quit Stanford University in 2004 at the age of 19 to start Theranos (a portmanteau of “therapy” and “diagnosis”), a biomedical company nestled in a leafy Palo Alto research park. For … [Read more...] about Theranos: how a medical fraud exposed Silicon Valley’s cult of disruption
3 To witness the UK return of actor and standup comedian Aziz Ansari, best known for his star-making role on the US comedy series Parks and Recreation and for creating and starring on the beloved Netflix tragicomedy Master of None, was to first have to venture into what had the feel of a Silicon Valley-sponsored prison. Alongside a litany of security guards, ticket holders were asked at the door to place all of their phones, smart watches and recording devices inside of specially designed fabric pouches locked and sealed by a magnet and provided for the event by a flashy San Francisco startup. Introduced to create an apparently “phone-free experience” for all, it was difficult not to interpret... Register for free to read this article, or log in to your Telegraph account Register Log in … [Read more...] about Aziz Ansari: Road to Nowhere, Eventim Apollo, review: A gig that burned with palpable unease
4 The tech industry mantra of “move fast and break things” was laid bare as a sociopath’s charter in The Inventor: Out for Blood in Silicon Valley (Sky Atlantic), Alex Gibney's riveting chronicling of the rise and fall of medical start-up Theranos. The fascinating void at the heart of the documentary was Elizabeth Holmes, the company’s founder and public face. Never blinking and with a smile that felt like a calculated performance of human emotion, she was an almost too-perfect embodiment of the dark side of American tech evangelism. Lies and machinations were all in a morning’s work for the chillingly assured Stanford drop-out (currently facing up to 20 years in prison for fraud). The underlings... Register for free to read this article, or log in to your Telegraph account Register Log in … [Read more...] about The Inventor: Out for Blood in Silicon Valley, review: a riveting chronicle of fraud on a massive scale
At the recent Geneva motor show, PSA boss Carlos Tavares announced “It will take 30 years,” referring to his long-term commitment to establishing the DS brand, which was only launched in 2015. His ambition is admirable; a week in the motor industry is a long time and so far DS has struggled to establish much of a foothold outside of its DS3 supermini in Europe. And do PSA’s shareholders hold this invented marque, named after an epochal but now almost forgotten Citroën, so closely to their hearts? Tavares might be well advised to carefully monitor his DS blind spot. Electrification, autonomous driving, the rise of Silicon Valley and Chinese car makers, low profitability and high investment continue... Register for free to read this article, or log in to your Telegraph account Register Log in … [Read more...] about DS3 Crossback review: refreshingly different, but is it really premium?